XML 33 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
shares in Thousands, $ in Thousands
Apr. 30, 2024
Apr. 30, 2023
Current Assets    
Cash and cash equivalents $ 23,267 $ 8,078
Restricted cash 2,671 5,737
Receivables, less allowance: $588 (2024); $476 (2023) 45,064 46,081
Inventories 20,679 21,889
Prepaid expenses and other current assets 5,136 6,135
Total Current Assets 96,817 87,920
Property, plant and equipment, net 17,649 16,402
Right of use assets 7,454 9,170
Deferred income taxes 7,401 0
Other assets 5,445 5,406
Total Assets 134,766 118,898
Current Liabilities    
Short-term borrowings 3,099 3,587
Current portion of financing liability 713 642
Current portion of financing lease liabilities 111 85
Current portion of operating lease liabilities 2,123 1,967
Accounts payable 23,262 23,599
Employee compensation and amounts withheld 6,041 4,304
Deferred revenue 4,374 4,097
Other accrued expenses 1,057 1,772
Total Current Liabilities 40,780 40,053
Long-term portion of financing liability 27,420 28,132
Long-term portion of financing lease liabilities 235 148
Long-term portion of operating lease liabilities 5,434 7,136
Accrued pension and deferred compensation costs 3,008 3,546
Deferred income taxes 1,218 943
Other non-current liabilities 462 455
Total Liabilities 78,557 80,413
Commitments and Contingencies (Note 10)
Stockholders' Equity    
Common stock 7,273 7,084
Additional paid-in capital 5,406 5,059
Retained earnings 47,514 28,761
Accumulated other comprehensive loss (3,382) (3,442)
Common stock in treasury, at cost: 70000 shares (2024); 3 shares (2023) (2,051) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 54,760 37,409
Non-controlling interest 1,449 1,076
Total Stockholders' Equity 56,209 38,485
Total Liabilities and Stockholders' Equity $ 134,766 $ 118,898
Treasury stock, shares (in shares) 70 3